ES2187390A1 - Un antiandrogeno topico para la perdida de cabello y otros estados hiperandrogenos. - Google Patents

Un antiandrogeno topico para la perdida de cabello y otros estados hiperandrogenos.

Info

Publication number
ES2187390A1
ES2187390A1 ES200150040A ES200150040A ES2187390A1 ES 2187390 A1 ES2187390 A1 ES 2187390A1 ES 200150040 A ES200150040 A ES 200150040A ES 200150040 A ES200150040 A ES 200150040A ES 2187390 A1 ES2187390 A1 ES 2187390A1
Authority
ES
Spain
Prior art keywords
hair loss
hair
hyperandrogenic conditions
effluvium
hirsutism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200150040A
Other languages
English (en)
Other versions
ES2187390B2 (es
Inventor
Sovak Allen L Milos
Jason W Brown
Brian Campion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOPHISICA Inc
Original Assignee
BIOPHISICA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOPHISICA Inc filed Critical BIOPHISICA Inc
Publication of ES2187390A1 publication Critical patent/ES2187390A1/es
Application granted granted Critical
Publication of ES2187390B2 publication Critical patent/ES2187390B2/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
    • C07C335/08—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/22—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C07D207/408—Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

El compuesto 2-hidroxi-2-metil-N-(4-X-3-propionamida) aplicado por vía tópica, inhibe y/o elimina específicamente los receptores de andrógenos cutáneos y, por tanto, encuentra un uso cosmético en afecciones de la piel asociados con un exceso de andrógenos tales como efluvio del cabello, hirsutismo, acné y alopecia andrógena.
ES200150040A 2000-02-11 2000-05-25 Un antiandrogeno topico para la perdida de cabello y otros estados hiperandrogenos. Expired - Fee Related ES2187390B2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/502,376 US6472415B1 (en) 1998-12-18 2000-02-11 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
US09/502376 2000-02-11

Publications (2)

Publication Number Publication Date
ES2187390A1 true ES2187390A1 (es) 2003-06-01
ES2187390B2 ES2187390B2 (es) 2004-04-01

Family

ID=23997526

Family Applications (2)

Application Number Title Priority Date Filing Date
ES00937913T Expired - Lifetime ES2215672T3 (es) 2000-02-11 2000-05-25 Anti-androgeno topico contra la caida del cabello y otras condiciones hiperandrogenicas.
ES200150040A Expired - Fee Related ES2187390B2 (es) 2000-02-11 2000-05-25 Un antiandrogeno topico para la perdida de cabello y otros estados hiperandrogenos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES00937913T Expired - Lifetime ES2215672T3 (es) 2000-02-11 2000-05-25 Anti-androgeno topico contra la caida del cabello y otras condiciones hiperandrogenicas.

Country Status (19)

Country Link
US (1) US6472415B1 (es)
EP (1) EP1169301B1 (es)
JP (1) JP4806508B2 (es)
KR (1) KR100508681B1 (es)
CN (1) CN100402492C (es)
AT (1) ATE259781T1 (es)
AU (3) AU2000253026A1 (es)
BR (1) BRPI0008439B1 (es)
CA (1) CA2400185C (es)
CZ (1) CZ301910B6 (es)
DE (2) DE60008360T2 (es)
ES (2) ES2215672T3 (es)
HK (2) HK1043692A1 (es)
IL (2) IL145728A0 (es)
MX (1) MXPA01006376A (es)
PL (1) PL201173B1 (es)
RU (1) RU2225390C2 (es)
WO (2) WO2001058854A1 (es)
ZA (1) ZA200206497B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828458B2 (en) * 2000-05-25 2004-12-07 Biophysica, Inc. Topical antiandrogen for hair loss and other hyperandrogenic conditions
FR2826263B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un compose anti-inflammatoire
US7355081B2 (en) * 2002-04-17 2008-04-08 The University Of North Carolina At Chapel Hill Curcumin analogues and uses thereof
JP2007500245A (ja) * 2003-06-10 2007-01-11 スミスクライン ビーチャム コーポレーション 化合物
US7467119B2 (en) * 2003-07-21 2008-12-16 Aureon Laboratories, Inc. Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
US7505948B2 (en) * 2003-11-18 2009-03-17 Aureon Laboratories, Inc. Support vector regression for censored data
US7483554B2 (en) * 2003-11-17 2009-01-27 Aureon Laboratories, Inc. Pathological tissue mapping
GB0324551D0 (en) * 2003-10-21 2003-11-26 Karobio Ab Novel compounds
ATE502298T1 (de) * 2003-12-19 2011-04-15 Univ California Verfahren und materialien zur beurteilung von prostatakrebstherapien
AU2005232526B2 (en) 2004-02-24 2011-06-23 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
WO2005086068A2 (en) * 2004-02-27 2005-09-15 Aureon Laboratories, Inc. Methods and systems for predicting occurrence of an event
US7761240B2 (en) * 2004-08-11 2010-07-20 Aureon Laboratories, Inc. Systems and methods for automated diagnosis and grading of tissue images
CN104803916B (zh) * 2004-11-16 2017-08-11 詹森药业有限公司 用作选择性雄激素受体调节剂(sarms)的杂环衍生物
FR2878156A1 (fr) * 2004-11-22 2006-05-26 Oreal Utilisation des composes de la famille des n-acylamino-amides comme agents apaisants
WO2006053790A1 (en) * 2004-11-22 2006-05-26 L'oreal Use of compounds of the n-acylaminoamide family as soothing or calming agents
FR2878155A1 (fr) * 2004-11-22 2006-05-26 Oreal Protection de la peau contre les alterations liees a un dysfonctionnement des mecanismes physiologiques d'apoptose
WO2006053789A1 (en) * 2004-11-22 2006-05-26 L'oreal Protection of the skin against deterioration linked to a stress-induced dysfunction of the apoptotic and immune defence processes
US7709517B2 (en) * 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
US7709516B2 (en) * 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
US20070048246A1 (en) * 2005-09-01 2007-03-01 Biophysica Research, Inc. Novel skin care compositions
EP1957059A1 (en) * 2005-11-21 2008-08-20 Hadasit Medical Research Services And Development Ltd. Androgen-receptor (ar) ligands for use in the treatment and diagnosis of ar-related pathologies
EP3412290B1 (en) * 2006-03-27 2021-03-03 The Regents of The University of California Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
CN101460467B (zh) * 2006-03-29 2012-09-19 加利福尼亚大学董事会 二芳基硫代乙内酰脲化合物
WO2008044033A1 (en) * 2006-10-11 2008-04-17 Astrazeneca Ab Amide derivatives
JP5535925B2 (ja) 2007-10-26 2014-07-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア アンドロゲン受容体調節物質としてのジアリールヒダントイン化合物
GB0722088D0 (en) * 2007-11-09 2007-12-19 Spirogen Ltd Pyrrolobenzodiazepines
AU2008339572B2 (en) 2007-12-21 2012-05-10 Astrazeneca Ab Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
TW201111378A (en) 2009-09-11 2011-04-01 Bayer Schering Pharma Ag Substituted (heteroarylmethyl) thiohydantoins
SI3124481T1 (en) 2010-02-16 2018-06-29 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and their use
CA3197676A1 (en) * 2010-09-27 2012-04-12 E.I. Du Pont De Nemours And Company Method for preparing 2-amino-n-(2,2,2-trifluoroethyl)acetamide
MY180834A (en) 2012-09-26 2020-12-10 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
EP3089974B1 (en) * 2013-12-31 2019-02-20 Ipsen Pharma S.A.S. Novel imidazolidine-2,4-dione derivatives
US10093613B2 (en) 2015-04-21 2018-10-09 Gtx, Inc. Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10865184B2 (en) 2015-04-21 2020-12-15 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10806720B2 (en) 2015-04-21 2020-10-20 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10654809B2 (en) 2016-06-10 2020-05-19 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
KR102481319B1 (ko) * 2016-06-10 2022-12-26 유니버시티 오브 테네시 리서치 파운데이션 선택적 안드로겐 수용체 분해제(sard) 리간드 및 이의 사용 방법
US11230523B2 (en) 2016-06-10 2022-01-25 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
AU2018351714A1 (en) 2017-10-16 2020-04-30 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
US11292782B2 (en) 2018-11-30 2022-04-05 Nuvation Bio Inc. Diarylhydantoin compounds and methods of use thereof
KR102417496B1 (ko) 2019-11-29 2022-07-06 (주)수파드엘릭사 안드로겐 수용체의 활성을 억제하는 폡타이드 및 이를 이용하는 화장료 조성물
CN117751099A (zh) * 2021-08-05 2024-03-22 中国药科大学 酰胺类化合物及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037430A2 (en) * 1998-12-18 2000-06-29 Biophysica, Inc. Use of androgen receptor suppressors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE28864T1 (de) 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
GB8617652D0 (en) 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
JPH05194204A (ja) * 1992-01-20 1993-08-03 Lion Corp 抗男性ホルモン剤
US5656651A (en) * 1995-06-16 1997-08-12 Biophysica Inc. Androgenic directed compositions
EP0918774B9 (en) * 1996-06-27 2002-04-10 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
JP3568325B2 (ja) * 1996-07-12 2004-09-22 株式会社ノエビア 抗アンドロゲン剤及び養毛剤並びに毛髪用化粧料

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037430A2 (en) * 1998-12-18 2000-06-29 Biophysica, Inc. Use of androgen receptor suppressors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
TUCKER, H. et al.: Nonsteroidal antiandrogens. Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides. J. Med. Chem., 1988, Vol. 31, pßginas 954-959. Pßgina 954. *
TUCKER, H. et al.: Resolution of the nonsteroidal antiandrogen 4'-cyano-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3'- (trifluoromethyl)-propionamide and the determination of the absolute configuration of the active enantiomer. J. Med. Chem., 1988, Vol. 31, pßginas 885-887. Pßgina 885. *

Also Published As

Publication number Publication date
PL350356A1 (en) 2002-12-02
CZ301910B6 (cs) 2010-07-28
KR20020089347A (ko) 2002-11-29
ES2215672T3 (es) 2004-10-16
BR0008439A (pt) 2002-04-23
WO2001058855A9 (en) 2002-10-31
CN100402492C (zh) 2008-07-16
CA2400185C (en) 2011-07-05
AU3685601A (en) 2001-08-20
WO2001058855A1 (en) 2001-08-16
HK1043692A1 (zh) 2002-09-20
IL145728A0 (en) 2002-07-25
BRPI0008439B1 (pt) 2016-04-19
DE10084380T1 (de) 2002-06-20
US6472415B1 (en) 2002-10-29
ZA200206497B (en) 2003-08-14
EP1169301B1 (en) 2004-02-18
IL145728A (en) 2008-04-13
WO2001058854A1 (en) 2001-08-16
CN1416416A (zh) 2003-05-07
MXPA01006376A (es) 2003-06-06
KR100508681B1 (ko) 2005-08-17
RU2225390C2 (ru) 2004-03-10
AU2001236856B2 (en) 2005-08-11
DE60008360T2 (de) 2004-12-09
DE60008360D1 (de) 2004-03-25
HK1051849A1 (en) 2003-08-22
CZ20012398A3 (cs) 2001-11-14
AU2000253026A1 (en) 2001-08-20
ATE259781T1 (de) 2004-03-15
JP2003522752A (ja) 2003-07-29
ES2187390B2 (es) 2004-04-01
PL201173B1 (pl) 2009-03-31
EP1169301A1 (en) 2002-01-09
JP4806508B2 (ja) 2011-11-02
CA2400185A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
ES2187390A1 (es) Un antiandrogeno topico para la perdida de cabello y otros estados hiperandrogenos.
CY1106089T1 (el) Σκευασματα για τοπικη εφαρμογη ουσιων που δρουν ως αντιανδρογονα
DE69717095D1 (de) Topische vitamin d zusammensetzung auf liposomenbasis
ZA200000372B (en) A hair lotion with improved properties in its hair protecting action and prevention of hair loss, and the reduction of external effects of androgenic alopecia and resulting hair loss.
MY101526A (en) Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
WO2004005407A3 (fr) Composés tétraazapentaméthiniques et leur application pour la teinture des fibres keratiniques
DE50014447D1 (de) Tablettierung verdickender systeme
WO2004103290A3 (en) Compositions comprising an amidine and an alkane polyol
EP1144366A3 (en) Use of androgen receptor suppressors
AU2002222047A1 (en) Composition for oxidation dyeing of keratinous fibres comprising a amino pyrazole and a cellulose compound
CA2392620A1 (en) Use of melatonin for the treatment of androgenetic and diffuse alopecia
CA2049729A1 (en) Methods and compositions containing vitamin d compounds for improvement of skin conditions
BR0115389A (pt) Composição cosmética, método cosmético e uso de composição tópica
GB9918022D0 (en) Skin care composition
MXPA04001249A (es) Reduccion del crecimiento del vello.
WO2001047477A3 (de) Mittel zum färben von keratinhaltigen fasern
AR032762A1 (es) 2-hidroxi-3-perfluoracilaminopropionamidas topico para la perdida del cabello y otras condiciones hiperandrogenicas, una formulacion cosmetica y farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento
BR9203266A (pt) Composto,formulacao farmaceutica,processo para inibir 5alfa-reductase,processos para tratar hiperplasia benigna da prostata,seborreia e alopecia androgenica
BR0009860B1 (pt) composiÇço cosmÉtica para uso tàpico e uso da composiÇço.
AU2002358073A1 (en) Use of ectoin and ectoin derivatives for the treatment of hair
WO2002041866A3 (en) Cosmetic composition
BR0015625A (pt) Produto para branqueamento dental, processo para aplicação do mesmo, formulação compreendendo um produto para branqueamento dental e utilização de um produto para branqueamento dental e de peroxidase
ES2152187B1 (es) Locion estimulante del foliculo piloso.
WO2000018358A3 (en) Method of treating hair loss using ketoamides
ES2151869A1 (es) Composicion de un producto de aplicacion a la piel.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030601

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2187390B2

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100312